Denys Gibbons1, Michael Camilleri1, Alfred D Nelson1, Deborah Eckert1. 1. Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Abstract
BACKGROUND: Gastrointestinal symptoms are frequent in multiple endocrine neoplasia (MEN) 2B and may be related to megacolon. OBJECTIVE: The objective of this article is to review the clinical features of patients with MEN 2B, particularly megacolon. METHODS: We used natural language processing of electronic medical records of Mayo Clinic patients over 20 years: Eight patients with definite MEN 2B were identified; of these, four had megacolon. From these patients' records, three others with paper medical records were identified through familial association. We used a standard data sheet to identify features of the disease with particular emphasis on megacolon. RESULTS: Of the 11 patients identified with MEN 2B, seven (63%) had megacolon, typically presenting with constipation in infancy or megacolon in childhood. In addition, three patients had esophageal manifestations (two achalasia and one Zenker's diverticulum). Megacolon often required surgical intervention for intractable constipation, abdominal distension and discomfort. Histopathological features of resected colon revealed enteric and extrinsic nerve hyperplasia and ganglioneuromas of the submucosal and myenteric plexuses. CONCLUSIONS: Among patients with MEN 2B, 63% had megacolon. Significant esophageal motor disorders in MEN 2B may affect ∼25% of patients. Any presentation with megacolon should trigger a search for MEN 2B in order to identify the potentially fatal endocrine tumors.
BACKGROUND: Gastrointestinal symptoms are frequent in multiple endocrine neoplasia (MEN) 2B and may be related to megacolon. OBJECTIVE: The objective of this article is to review the clinical features of patients with MEN 2B, particularly megacolon. METHODS: We used natural language processing of electronic medical records of Mayo Clinic patients over 20 years: Eight patients with definite MEN 2B were identified; of these, four had megacolon. From these patients' records, three others with paper medical records were identified through familial association. We used a standard data sheet to identify features of the disease with particular emphasis on megacolon. RESULTS: Of the 11 patients identified with MEN 2B, seven (63%) had megacolon, typically presenting with constipation in infancy or megacolon in childhood. In addition, three patients had esophageal manifestations (two achalasia and one Zenker's diverticulum). Megacolon often required surgical intervention for intractable constipation, abdominal distension and discomfort. Histopathological features of resected colon revealed enteric and extrinsic nerve hyperplasia and ganglioneuromas of the submucosal and myenteric plexuses. CONCLUSIONS: Among patients with MEN 2B, 63% had megacolon. Significant esophageal motor disorders in MEN 2B may affect ∼25% of patients. Any presentation with megacolon should trigger a search for MEN 2B in order to identify the potentially fatal endocrine tumors.
Authors: Sara Nullens; Tyler Nelsen; Michael Camilleri; Duane Burton; Deborah Eckert; Johanna Iturrino; Maria Vazquez-Roque; Alan R Zinsmeister Journal: Gut Date: 2011-12-16 Impact factor: 23.059
Authors: Cleber P Camacho; Ana O Hoff; Susan C Lindsey; Priscila S Signorini; Flávia O F Valente; Mariana N L Oliveira; Ilda S Kunii; Rosa Paula M Biscolla; Janete M Cerutti; Rui M B Maciel Journal: Arq Bras Endocrinol Metabol Date: 2008-11
Authors: Renata Pomahacova; Petra Paterova; Eva Nykodymova; Eliska Vaclavikova; Pavla Sykorova; Katerina Personova; Ramir Katra; Ivan Subrt; Josef Sykora Journal: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Date: 2021-08-24 Impact factor: 1.245
Authors: Michael Camilleri; Eric Wieben; Deborah Eckert; Paula Carlson; Ralph Hurley O'Dwyer; Denys Gibbons; Andres Acosta; Eric W Klee Journal: Neurogastroenterol Motil Date: 2019-01-20 Impact factor: 3.598
Authors: Medard F M van den Broek; Ester B G Rijks; Peter G J Nikkels; Victorien M Wolters; Robert J J van Es; Hanneke M van Santen; Bernadette P M van Nesselrooij; Menno R Vriens; Rachel S van Leeuwaarde; Gerlof D Valk; Annemarie A Verrijn Stuart Journal: Endocrine Date: 2021-01-21 Impact factor: 3.633
Authors: Jutta Keller; Gabrio Bassotti; John Clarke; Phil Dinning; Mark Fox; Madhusudan Grover; Per M Hellström; Meiyun Ke; Peter Layer; Carolina Malagelada; Henry P Parkman; S Mark Scott; Jan Tack; Magnus Simren; Hans Törnblom; Michael Camilleri Journal: Nat Rev Gastroenterol Hepatol Date: 2018-04-06 Impact factor: 46.802